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Abstract
Background: The polymorphic membrane protein D (PmpD) in Chlamydia is structurally similar to autotransporter proteins
described in other bacteria and may be involved in cellular and humoral protective immunity against Chlamydia. The
mechanism of PmpD post-translational processing and the role of its protein products in the pathogenesis of chlamydial
infection have not been very well elucidated to date.
Methodology/Principal Findings: Here we examined the expression and post-translational processing of the protein
product of the pmpD gene during the life cycle of C. trachomatis serovars A, D, and L2. Each of these three serovars targets
different human organs and tissues and encodes a different pmpD gene nucleotide sequence. Our quantitative real-time
reverse transcription polymerase chain reaction results demonstrate that the pmpD gene is up-regulated at 12–24 hours
after infection regardless of the Chlamydia serovar. This up-regulation is coincidental with the period of exponential growth
and replication of reticulate bodies (RB) of Chlamydia and indicates a probable similarity in function of pmpD in serovars A,
D, and L2 of Chlamydia. Using mass spectrometry analysis, we identified the protein products of post-translational
processing of PmpD of C. trachomatis serovar L2 and propose a double pathway model for PmpD processing, with one
cleavage site between the passenger and autotransporter domains and the other site in the middle of the passenger
domain. Notably, when Chlamydia infected culture cells were subjected to low (28uC) temperature, PmpD post-translational
processing and secretion was found to be uninhibited in the resulting persistent infection. In addition, confocal microscopy
of cells infected with Chlamydia confirms our earlier hypothesis that PmpD is secreted outside Chlamydia and its secretion
increases with growth of the chlamydial inclusion.
Conclusion/Significance: The results of this current study involving multiple Chlamydia serovars support the general
consensus that the pmpD gene is maximally expressed at mid infection and provide new information about PmpD as an
autotransporter protein which is post-translationally processed and secreted outside Chlamydia during normal and low
temperature induced persistent chlamydial infection.
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Introduction
C. trachomatis, an obligate intracellular bacterium, is an
important human pathogen causing a variety of infections. Based
on their tissue tropism, Chlamydia serovars are subdivided into
several disease groups: ocular (serovars A-C), urogenital (serovars
D-K), and Lymphogranuloma Venereum (LGV) (serovars L1-L3).
Since the genome of C. trachomatis serovar D/UW-3 was first
described in 1998, the genomes of three more C. trachomatis
serovars, A/HAR13, L2/434/Bu, and L2b/UCH-1/proctitis,
each of which targets specific human organ and tissues, have
been determined [1–3]. Genomic analysis of these Chlamydia
strains and C. muridarum (formerly C. trachomatis MoPn) revealed
several genes including the family of the polymorphic membrane
protein (pmp) genes with varying degrees of single nucleotide
polymorphisms (SNP) which were suggested to be associated with
Chlamydia tissue tropism and pathogenesis for each disease group
[2–10]. In addition, recent clinical isolates and laboratory
prototype strains of the same Chlamydia serovars that have been
passaged in the laboratory for decades may also differ in their
genomic composition which may influence the outcomes of in vitro
and in vivo studies involving prototype strains and/or clinical
isolates [11,12]. Further, Kari et al [12] first demonstrated that
even slight variations in genomic sequence between some ocular
strains of C. trachomatis may have an effect on the pathogenesis of
trachoma.
Alignment of the sequence of the pmpD gene, a member of the
pmp family, in C. trachomatis serovars A, D, and L2, available in the
GenBank, revealed relatively high nucleotide variability between
serovar L2 and both A and D and very low variability between
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5191serovars A and D (Table 1). The protein product of this gene is
structurally similar to autotransporter (AT) proteins described in
other bacteria [13] and it has been shown to be significantly
involved in cellular and humoral protective immunity against
chlamydial infection thus, making it a prospective candidate in
vaccine development [11,14–18].
In our most recent publication, we demonstrated that the pmpD
gene was up-regulated at 16–24 hours (h) post infection (p.i.) for
serovar L2, which coincides with the period of exponential growth
and replication of reticulate bodies (RB) [19]. This finding
generally agrees with the results of other investigators who
examined regulation of several chlamydial genes including
pmpD/pmp21 during the life cycle of C. trachomatis serovars D and
L2 and C. pneumoniae CWL029 [20–22]. However, Nunes et al [11]
showed that the pmpD gene in C. trachomatis serovars E and L2 was
the latest (36 h p.i.) up-regulated gene among all pmps, suggesting
its involvement in transformation of RBs to elementary bodies
(EB). Additionally, in our previous work [19], we first demon-
strated that similar to bacterial AT proteins, the full length
<160 kDa PmpD undergoes post-translational processing during
the life cycle of C. trachomatis serovar L2 with formation of the
presumable <120 kDa passenger domain (PD) and smaller <80
and 65 kDa products. We also found PmpD initially localized on
the surface of RBs followed by its cleavage and secretion outside
Chlamydia. However, the protein products of PmpD post-
translational processing were not identified and the mechanism
of processing was not clearly understood at that time.
While this manuscript was being considered for publication,
Swanson et al proposed multistep processing of PmpD which
results in an initial formation of Chlamydia-associated 73 and
82 kDa fragments and subsequent secretion of 111, 73, and
30 kDa fragments outside Chlamydia later in chlamydial life cycle
[18]. Wehrl et al [16] suggested another mechanism of PmpD
processing in C. pneumoniae which involves cleavage of PmpD with
initial formation of a 130 kDa passenger domain followed by
cleavage of the PD into two smaller 70 and 55 kDa fragments.
To gain further insight into the transcription of the pmpD gene
and post-translational processing and localization of its protein
product in LGV and non-LGV C. trachomatis strains in this current
study, we examined pmpD transcription in serovars A, D, and L2.
These three serovars were chosen because they have different
human organ and tissue tropism. In addition to the prototype
strains, we examined pmpD transcription in clinical isolates of C.
trachomatis serovars D and L2. Using mass spectrometry (MS)
analysis, we identified the protein products of post-translational
processing of PmpD of C. trachomatis serovar L2 and proposed a
mechanism of PmpD processing which is different from that
described by Swanson et al [18]. Further, the mode of action of
penicillin on PmpD post-translational processing described in our
previous work [19] was not known at that time. To determine if
penicillin directly suppresses serine proteases [23] or blocks the
conversion from RBs to EBs [24,25], PmpD post-translational
processing was studied during persistent chlamydial infection
induced by low (28uC) temperature. This condition mimics the
action of penicillin by inhibiting the development of RBs [26], but
has an unknown effect on proteases. Because PmpD was found to
be processed at 28uC, we concluded that penicillin specifically
inhibits chlamydial serine proteases including signal peptidase I
involved in different stages of PmpD processing, thus supporting
the general mechanism of post-translational processing of PmpD
of C. trachomatis as that of an autotransporter protein.
Methods
Bacterial Strains
The C. trachomatis L2 prototype strain 434/Bu, L2 clinical isolate
663 passaged 13 times in our laboratory since isolation, D
prototype strain UW-3/Cx, D clinical isolate 9247 passaged 18
times, and A prototype strain HAR-13 were grown in McCoy cells
(ATCC CRL 1696), harvested, and purified as described
previously [19]. The clinical isolates were kindly provided by R.
Suchland (University of Washington, Seattle, WA). The serotype
of each Chlamydia strain was confirmed with monoclonal antibodies
as described by Suchland and Stamm [27].
Quantification of pmpD gene expression by quantitative
real-time RT-PCR
To study the temporal transcription of the pmpD gene relative to
the transcription of 16S RNA in both prototype and clinical
isolates of C. trachomatis serovars D and L2 and in the prototype
strain of C. trachomatis serovar A, total RNA was isolated from
infected McCoy cells at 2 (L2), 4, 6 (L2), 8, 12, 24, 30 (A), 36, 48,
54 (A), 60 (D), and 72 (D) hours (h) post infection (p.i.) and cDNA
was synthesized as described previously [19]. Chlamydial genomic
DNA was isolated from purified EBs of each strain with the
DNeasy Tissue Kit (Qiagen, Valencia, CA) and used to make
standards by 10-fold dilutions of known copy numbers of DNA
based on its molecular mass. Real-time RT-PCR was conducted in
a LightCycler Instrument (Roche Applied Science, Indianapolis,
IN) using gene specific primer sets for 16S RNA [28] and pmpD
[19]. A minimum of three PCR assays were performed for each
time point using each gene specific primer set and the calculated
copy numbers for each gene at each time point were averaged.
Relative pmpD expression at each time point was calculated by
dividing the average pmpD copy number by the average 16S RNA
copy number at the same time point and multiplying by 1610
6
[29]. Statistical error was calculated using the standard error of the
mean [29].
Fractionation of McCoy cells infected with different C.
trachomatis serovars
McCoy cell monolayers in six-well tissue culture plates
(CORNING Inc., Corning, NY) were infected with C. trachomatis
serovar A and D at a multiplicity of infection (MOI) of 1 and
soluble and insoluble fractions were prepared at 24, 48, and 72 h
p.i. and loaded onto a 10% gel as previously described [19]. In
addition, a second approach was used to identify secreted proteins
of C. trachomatis serovar L2 based on differential extraction of
proteins from infected cells according to their subcellular
localization by using the ProteoExtractH Subcellular Proteome
Extraction Kit (EMD Biosciences Inc., San Diego, CA). Briefly,
Table 1. Comparative analysis of the pmpD gene nucleotide
sequence in C. trachomatis serovars A, D, and L2.
Chlamydia serovars
whose pmpD sequence
are aligned in BLAST
Total number
of SNPs
Number of
non-synonymos SNPs
L2/D 17* 9
L2/A 16* 10
D/A 7 3
*not including 3 nucleotide deletions in the L2 sequence
The pmpD gene nucleotide sequence in C. trachomatis serovars A, D, and L2 are
available in GenBank deposited by Carlson et al [2], Stephens et al [1], and
Thomson et al [3] respectively.
doi:10.1371/journal.pone.0005191.t001
PmpD in C. trachomatis
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L2 at an MOI of 1 and at 48 h p.i., after several washes with
phosphate buffered saline (PBS), cells were subsequently treated
with different extraction buffers according to the manufacturer’s
instructions. The proteins present in each extraction buffer were
precipitated with trichloroacetic acid (TCA) (Fisher Scientific, Fair
Lawn, NJ), washed twice in cold acetone, and resuspended in an
equal amount of Lammli buffer [30].
1D-PAGE and immunoblotting
After the insoluble fractions prepared at specified time points
after infection were normalized against chlamydial MOMP, equal
volumes of the soluble fractions were loaded onto a 10% gel as
described previously [19]. The chlamydial proteins separated by
SDS-PAGE were transferred to a nitrocellulose membrane,
blocked, and washed according to standard procedures [31].
The membrane was incubated with pAb against the major outer
membrane protein (MOMP) (Virostat, Portland, ME) or pAb
against fragment 2 of PmpD (the N-terminal portion of the
passenger domain of PmpD (amino acid 470–818)) [19] diluted in
2.5% non-fat milk-Trizma buffer saline-Tween 20 (NFM-TBST)
and, after multiple washes in TBST, with the corresponding
secondary antibody conjugated with alkaline phosphatase (AP)
(Sigma-Aldrich). Blots were developed with BCIP/NBT (5-
Bromo-4-Chloro3’-Indolylphosphate p-Toluidine salt/Nitro-blue
Tetrazolium Chloride) according to the manufacturer’s instruc-
tions (Pierce, Rockford, IL). To assess the efficiency of differential
extraction of proteins from McCoy cells infected with Chlamydia,
the proteins in each extract were probed in an immunoblot with
mouse monoclonal antibodies against glyceraldehyde 3 phosphate
dehydrogenase (GAPDH) (Abcam, Cambridge, MA), a host cell
marker protein, followed by incubation with anti-mouse IgG
conjugated with AP (Promega, Madison, WI) and development as
described above.
2-D PAGE and immunoblotting
The proteins in the soluble fraction prepared from McCoy cells
infected with C. trachomatis serovar L2 at 48 h p.i. were separated
by 2-D electrophoresis, which was performed using the carrier
ampholine method of isoelectric focusing [32] by Kendrick Labs,
Inc. (Madison, WI) followed by staining the 2D gel with
Coomassie Brilliant Blue R-250 (Sigma Aldrich). An identical
gel, which was run in parallel with the first gel, was transblotted
onto PVDF membrane followed by incubation with antibodies
against fragment 2 of PmpD and development as described above.
Protein spots reacting with antibodies in the immunoblot were
Figure 1. Relative pmpD transcription in prototype and clinical isolate strains of C. trachomatis serovar L2 (A), D (B), and A (C). Total
RNA was isolated from Chlamydia infected McCoy cells at 2 (L2), 4, 6 (L2), 8, 12, 24, 30 (A), 36, 48, 54 (A), 60 (D), and 72 (D) h p.i., and from purified EBs,
random primed, and assayed by real-time RT-PCR for 16S rRNA and pmpD copy numbers. Relative pmpD expression at each time point was calculated
by dividing the average pmpD copy number by the average 16S RNA copy number at the same time point and multiplying by 1610
6 [29]. Error bars
were based on the standard error of the mean [29]. Note that serovar A pmpD expression levels are much higher than levels in serovars D and L2.
doi:10.1371/journal.pone.0005191.g001
Figure 2. PmpD processing and secretion in C. trachomatis
serovar A. McCoy cells infected with C. trachomatis serovar A were
harvested at 24, 48, and 72 h p.i., and soluble and insoluble protein
fractions prepared and loaded as described in METHODS. The proteins
in the soluble fractions were reacted in an immunoblot with antibodies
against fragment 2 of PmpD. Data not shown for PmpD in the insoluble
fractions. Antibodies against MOMP and GAPDH were reacted with
both the soluble and insoluble fractions to assess the efficiency of their
separation. Soluble fractions: Lanes 1–3; Insoluble fractions: Lanes 4–6.
Lanes 1 and 4, 24 h p.i. Lanes 2 and 5, 48 h p.i. Lanes 3 and 6, 72 h p.i.;
Note that the PmpD post-translational products and the GAPDH protein
are found exclusively in the soluble fractions while chlamydial MOMP is
found in the insoluble fractions which contain chlamydial organisms.
doi:10.1371/journal.pone.0005191.g002
Figure 3. Differential extraction of proteins from culture cells
based on their subcellular localization. McCoy cells infected with
C. trachomatis serovar L2 were subsequently treated at 48 h p.i. with
different Extraction buffers (CalbiochemH). The proteins in each extract
were loaded in equal volumes and reacted in an immunoblot with
antibodies against fragment 2 of PmpD, MOMP, and GAPDH. Lane 1,
Cytosolic fraction (Extract I). Lane 2, Membrane and membrane
organelles (Extract II). Lane 3, Nuclear fraction (Extract III). Note that
the PmpD post-translational products and the GAPDH protein are
found exclusively in the cytosolic fraction and almost all of the
chlamydial MOMP is found in the subsequent fractions which contain
chlamydial organisms.
doi:10.1371/journal.pone.0005191.g003
PmpD in C. trachomatis
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by mass spectrometry fingerprinting.
Mass spectrometry analysis and database search
MS analysis of the proteins of interest was carried out at the
Protein Core Facility at Columbia University, New York, NY. Gel
spots were prepared for digestion by washing twice with 100 ml
30% acetonitrile in 0.05M Tris, pH 8.5 for 20 min with shaking,
then with 100% acetonitrile for 1–2 min. After removing the
washes, the gel pieces were dried for 30 min in a Speed-Vac
concentrator. Gels were digested by adding 0.06 mg modified
trypsin (sequencing grade, Roche Molecular Biochemicals) in 13–
15 ml 0.025 M Tris, pH 8.5. The tubes were placed in a heating
block at 32uC and left overnight. Peptides were extracted twice
with 50 ml 50% acetonitrile/2% trifluoroacetic acid (TFA) and
Figure 4. Peptides identified by MS in the <65 kDa protein spot (raw data). The peptides identified by MS are highlighted in red.
doi:10.1371/journal.pone.0005191.g004
PmpD in C. trachomatis
PLoS ONE | www.plosone.org 5 April 2009 | Volume 4 | Issue 4 | e5191reduced in volume in a Speed-Vac concentrator. Each dried digest
was subsequently dissolved in 3 ml matrix/standard solution
(10 mg/ml solution of 4-hydroxy-a-cyanocinnamic acid in 50%
acetonitrile/ 0.1% TFA plus two internal standards, angiotensin I
and adrenocorticotropic hormone (ACTH) 7–38 peptide) and
0.6 ml was spotted onto a sample plate. When the spot was
completely dried, it was washed twice with ultra pure water.
MALDI mass spectrometric analysis was performed on the digest
using an Applied Biosystems Voyager DE Pro mass spectrometer
in the linear mode. Instrument settings were as follows:
Accelerating voltage: 20,000 V; Grid voltage: 95%; Guide wire:
0.05%; Extraction delay time: 200 nsec. Each spectrum was
smoothed using Gaussian smoothing (filter width=19 points) and
calibrated using two-point calibration with the internal standards
angiotensin I (1297.51) and ACTH 7-38 (3660.19). Data obtained
by MALDI-TOF was searched using the ProFound protein
Figure 5. Peptides identified by MS in the <120 kDa protein spot (raw data). The peptides identified by MS are highlighted in red.
doi:10.1371/journal.pone.0005191.g005
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profound.exe. Average MH+ values were entered manually.
Internal standards of keratin and trypsin autodigestion products
at 2164.33 and 2274.60 were excluded. Search parameters were as
follows: Database: NCBInr (2007/06/01); Taxonomy category:
Bacteria; Protein mass range: 0–3000 kDa; Protein pI range: 0.0–
14.0; Digest chemistry: trypsin, 1 max missed cuts; Modifications:
+C3H5ON@C (Complete), +O@M (Partial); Tolerance: 0.50 Da
Immunofluorecence (IMF) microscopy
To examine PmpD localization, McCoy cells grown on
coverslips were infected with C. trachomatis serovar L2. At 16, 24,
36, and 48 h p.i., cells were fixed with 100% methanol, washed in
PBST, and reacted with the mouse monoclonal antibody (mAb)
LV-22 [27] against MOMP of C. trachomatis, rabbit pAb against
fragment 2 of PmpD, or chlamydial heat-shock protein (HSP 60)
(kindly provided by R. Morrison), diluted in 2.5% bovine serum
Figure 6. Peptides identified by MS in the <80 kDa protein spot (raw data). The peptides identified by MS are highlighted in red.
doi:10.1371/journal.pone.0005191.g006
PmpD in C. trachomatis
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temperature. In addition, newly generated rabbit pAb against
PmpA (aa 64–548), which contrary to other Pmps lacks a signal
sequence, and mouse mAb against IncA, a type III secreted
protein [33] (kindly provided by D. Rockey), were also used in this
study. After washing in PBS, the primary stained monolayer was
reacted with goat anti-mouse IgG+IgM (H+L) antibodies conju-
gated with FITC (Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA) and goat anti-rabbit IgG antibodies conjugated
with Texas Red (Molecular probes, Inc., Eugene, OR) or donkey
anti-mouse IgG conjugated with Alexa 594 (Molecular probes,
Inc.). Coverslips were washed, mounted, and examined using a
Leica confocal system.
Examination of PmpD post-translational processing and
localization during low (28uC) temperature induced
persistent Chlamydia infection
McCoy cells in six-well plates were infected with C. trachomatis
serovar L2 at an MOI of 7 and, after centrifugation at 1,2006g for
1 hour, were initially incubated at 37uC for 6–8 hours to allow EBs
to transform to RBs and then at 28uC for up to 192 hours after
infection to inhibit RB to EB transformation [26]. To enhance cell
viability during the infection, Eagle’s minimal essential medium
(Sigma Aldrich, St. Louis, MO) supplemented with 1 mg/ml L-
glutamine, 0.5 mg/ml cycloheximide, and 10% fetal bovine serum
(HyClone, Logan, UT) was replaced every 48 hours. Infected cells
were rinsed with PBS then harvested at 48, 96, 144, and 192 h p.i,
and soluble and insoluble fractions prepared as described
previously [19]. For confocal microscopy, McCoy cells infected
with Chlamydia and incubated at 28uC were fixed with methanol at
48 and 120 h p.i., washed in PBST, and stained with antibodies as
described above. Coverslips were washed, mounted, and exam-
ined using a Leica confocal system.
Results
PmpD relative transcription in different Chlamydia strains
The expression profile of the pmpD gene in prototype C.
trachomatis serovars A, D, and L2 showed that at the early time
points, up to 8 h after infection, the pmpD gene expression level
was very low (Fig. 1) and did not significantly differ from the level
observed in purified EBs. PmpD expression increased sharply and
peaked at 12–24 h p.i. during the exponential growth and division
of chlamydial RBs, then decreased but remained higher than that
observed at the earliest hours after infection. In clinical isolates of
serovars D and L2, pmpD expression followed the same general
pattern as in the prototype strains, peaking at 12 (serovar L2) and
24 (serovar D) h p.i., then decreasing and/or remaining stable
until the end of the course of infection. However, pmpD relative
expression in the prototype strains during exponential growth and
replication of Chlamydia (8–24 h p.i.) significantly exceeded that
observed in clinical isolates.
Detection of PmpD post-translational products by
immunoblotting analysis
The proteins in the soluble fractions prepared at specified time
points after infection of McCoy cells with C. trachomatis serovar A
were probed with antibodies against fragment 2 of PmpD in an
immunoblot (Fig. 2). A <157 kDa protein reacted strongly at all
time points examined while <120, 80, and 65 kDa protein bands
reacted strongly only at 48 and 72 h after infection. At 24 h p.i.,
the 120 kDa band appeared very weak and no <80 and 65 kDa
protein bands were detected. An identical reaction pattern was
observed with proteins in the soluble fractions obtained from cells
infected with C. trachomatis serovar D (not shown) and in previously
published results with L2 [19]. No reaction was observed with a
total protein lysate prepared from uninfected McCoy cells used as
Figure 7. Position of PmpD post-translational products iden-
tified by MS in the PmpD aa sequence. A.The full length PmpD of
C. trachomatis serovar L2. B. Position of the PmpD post-translational
products in the PmpD sequence.
doi:10.1371/journal.pone.0005191.g007
Figure 8. The amino acid sequence of the PmpD fragments
used to raise antibodies and antibody reaction with proteins
present in the soluble fraction. A. The amino acid sequence of the
PmpD fragments used to raise antibodies (Fragment 1, aa 17–517;
fragment 2, aa 470–818; fragment 3, aa 819–1180; fragment 4, aa 1174–
1531). B. Reaction of antibodies raised against PmpD fragments with
proteins present in the soluble fraction. McCoy cells infected with C.
trachomatis serovar L2 were harvested at 48 h p.i. and the soluble
fraction was prepared as described in METHODS. Lane 1, pAb against
fragment 1. Lane 2, pAb against fragment 2. Lane 3, pAb against
fragment 3. Lane 4, pAb against fragment 4.
doi:10.1371/journal.pone.0005191.g008
PmpD in C. trachomatis
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of the <157 and 80 kDa proteins in the soluble fractions in our
experiments may be due to partial damage of the chlamydial
organisms which occurred during the fractionation procedure
since the cell wall of the chlamydial RBs is sensitive to mechanical
factors [34]. In support of this, we found the chlamydial
cytoplasmic HSP60 protein in the soluble fractions using
antibodies against this protein [19]. In another approach utilizing
different Extraction Buffers from a ProteoExtractH Subcellular
Proteome Extraction Kit, we found the <120 and 65 kDa secreted
PmpD post-translational products and the host cell cytoplasmic
protein, GAPDH, in the material obtained at 48 h after infection
with C. trachomatis serovar L2 which contains cytosolic proteins
from the host cells and the chlamydial inclusion lumen (Extraction
Buffer I) (Fig. 3). At the same time, almost all of MOMP was
detected in the extracts enriched in membranes, membrane
organelles, chlamydial organisms inside inclusions, and nuclear
fractions (Extraction Buffers II and III respectively).
Identification of PmpD post-translational products
In our earlier study using MS analysis, we identified one of the
proteins which reacted with antibodies against fragment 2 of
PmpD, the <157 kDa protein, as the nearly full length PmpD
[19]. In this work, MS analysis of the <120 and 65 kDa proteins
revealed that they lack the peptides located in the signal sequence
and the transporter domain (TD) (the beta-barrel) (Fig 4 and 5).
Moreover, the <65 kDa protein contained peptides identical to
those located in the N-terminal half (aa 68–698) of the 120 kDa
passenger domain of PmpD (aa 68–1016) (Fig 7). The peptides
found in the <80 kDa protein began where the peptides of the
<65 kDa protein ended and consisted of the C-terminal half of the
PD and the full beta-barrel (aa 699–1482) (Fig 6 and 7). Analyzing
the proteome of purified EBs of C. trachomatis serovars A and D,
Shaw et al [35] found a protein with a very similar molecular
weight (87.4 kDa) whose peptides ‘‘were all located in the C-
terminal part’’ of PmpD. In addition to the results obtained from
mass spectrometry, proteins present in the soluble fraction
prepared after 48 h of infection of McCoy cells with C. trachomatis
serovar L2 were probed with antibodies generated against other
fragments of PmpD [19]. Each antibody reaction strongly
correlated with the peptide fragment of PmpD against which the
antibodies were generated (Fig. 8A). Thus, antibodies against
fragment 1 did not react with the <80 kDa protein band,
antibodies against fragment 3 did not react with the <65 kDa
band, and antibodies against fragment 4 (the beta-barrel) reacted
with neither the <120 nor 65 kDa proteins (Fig. 8B).
Detection of PmpD post-translational products outside
Chlamydia in IMF microscopy
IMF microscopy of Chlamydia infected McCoy cells fixed at
specified time points after infection and double stained with
antibodies against MOMP and fragment 2 of PmpD or the HSP60
protein demonstrated that at 16 h p.i., PmpD was found strictly on
the surface of chlamydial RBs (Fig. 9A). A small amount of
reactive protein material was clearly visible outside chlamydial
particles at 24 h p.i., but much more protein inside the inclusion
lumen was visible at 48 h after infection (Fig. 9B–D), which is in
agreement with the results of Swanson et al [18]. No such protein
material was observed outside Chlamydia in infected culture cells
stained with antibodies against MOMP (localized on the surface of
Chlamydia), HSP60 (Fig 9E–H), PmpA (internal protein controls)
(Fig 10C–D) or IncA, which is secreted outside Chlamydia and
Figure 9. The passenger domain of PmpD is secreted outside Chlamydia and accumulated in the inclusion lumen during the life
cycle of C. trachomatis. McCoy cells were infected with C. trachomatis serovar L2 and fixed with methanol at 16 (A and E), 24 (B and F), 36 (C and G),
and 48 (D and H) h p.i. and reacted with mAb against chlamydial MOMP (green) in combination with pAb against fragment 2 of PmpD (red) (A–D) or
pAb against chlamydial HSP60 protein (red) (E–H) (internal control). Arrow indicates localization of PmpD during the chlamydial life cycle on the
surface of Chlamydia (A) or in the inclusion lumen outside Chlamydia (red spots) (B–D). When reacted with anti-HSP60 pAb, no material was visible
outside Chlamydia. The photographs were made using a Leica SL confocal microscope.
doi:10.1371/journal.pone.0005191.g009
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McCoy cells were infected with C. trachomatis serovar L2, fixed with methanol at 24 (A, C, and E) and 48 (B, D, and F) h p.i., and reacted with mAb
against chlamydial MOMP (green) in combination with pAb against fragment 4 of PmpD (A and B), pAb against chlamydial PmpA (C and D), or mAb
against chlamydial IncA (E and F) (red). PmpA is localized in the cytoplasm while IncA is secreted outside Chlamydia and localized to the inclusion
membrane. The beta-barrel (transporter domain) alone and included in the <80 kDa protein, remains associated with the interior of the cell wall of
Chlamydia resulting in staining of chlamydial RBs with pAb against fragment 4 of PmpD in a doughnut-like pattern. Note, that contrary to pAb
against fragments 1, 2, and 3, pAb against fragment 4 do not stain unfixed chlamydial RBs (not shown). The photographs were made using a Leica SL
confocal microscope.
doi:10.1371/journal.pone.0005191.g010
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against other PmpD fragments, with the exception of fragment 4,
stain McCoy cells infected with Chlamydia similarly to antibodies
against fragment 2 (not shown). Antibodies against fragment 4 (the
beta-barrel) showed that this portion of PmpD is not secreted and
remains in the cell wall of Chlamydia (Fig 10A–B) as a part of the
<80 kDa protein. Similarly to antibodies against fragments 1, 2,
and 3, antibodies against fragment 4 stained RBs inside inclusions
in host cells infected with Chlamydia and fixed with methanol in a
doughnut-like staining pattern. However, contrary to antibodies
against other PmpD fragments, antibodies against fragment 4 do
not stain unfixed purified RBs (not shown), indicating that the
beta-barrel is not localized on the surface of Chlamydia. In addition,
no stained material was visible outside the inclusion.
Examination of PmpD post-translational processing and
localization during low (28uC) temperature induced
chlamydial persistent infection
Chlamydia infected McCoy cells were constantly monitored using
inverted light microscopy during the time course of 192 h p.i.,
which revealed formation of multiple small non-fusogenic or single
‘‘empty’’ looking giant inclusions (Fig 11). IMF microscopy of
infected McCoy cells fixed at 48 and 120 h p.i. and double stained
with antibodies against MOMP and PmpD/HSP60 exposed
inclusions filled with abnormally large aberrant RBs with a thin
cell wall compared with uniformly sized and round shaped RBs
produced by normal infection (Fig 12), suggesting persistent
infection in culture cells. These RBs were stained in a pattern very
similar to that observed in a normal infection, with HSP60 localized
inside and PmpD and MOMP on the surface of RBs. In addition, a
small amount of protein material stained with pAb against PmpD
was clearly visible outside chlamydial RBs at 120 h p.i., indicating
PmpD secretion, however at a much lower and slower rate
compared with normal (37uC) chlamydial infection. An immuno-
blot with soluble fractions prepared from McCoy cells infected with
Chlamydia, incubated at 28uC, and prepared at 48, 96, 144, and
192 h p.i., showed the <120 and 65 kDa protein bands in the 96–
192 h p.i. materials reacted with anti-PmpD antibodies (Fig. 13),
indicating that the PmpD protein was post-translationally processed
and secreted outside Chlamydia and confirming the results of IMF
microscopy. To ensure that the 192 h p.i. insoluble material
contained no viable infectious particles (chlamydial EBs),it wasused
to infect McCoy cells in 96-well tissue culture plates (CORNING).
Cells were stainedwithantibodies against MOMP and examined by
IMF microscopy 48 h after infection. McCoy cells seeded with
material obtained at 192 h p.i. after incubation at 28uC contained
no inclusions. At the same time, chlamydial inclusions were seen in
cells seeded withcontrolmaterial obtained from infected cells which
were incubated for 48 h at 37uC.
Figure 11. Chlamydial inclusions in culture cells produced by
low (28uC) temperature induced persistent infection. McCoy
cells were infected with C. trachomatis serovar L2, fixed with methanol
at 24 (A) h p.i. at 37uC and 48 (B) and 120 (C) h p.i. at 28uC and reacted
with pAb against fragment 2 of PmpD followed by staining with anti-
rabbit IgG conjugated with FITC (Sigma-Aldrich) and counterstaining
with Evans Blue. Multiple small non-fusogenic (B) or single ‘‘empty’’
looking giant (C) inclusions stained green are produced by persistent
infection. A single inclusion filled with typical RBs produced by normal
(37uC) infection (A) is shown for comparison. The photographs were
made using Nikon Eclipse E600 upright microscope with a QImaging
Retigia EX CCD Camera.
doi:10.1371/journal.pone.0005191.g011
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To determine if the variation in the pmpD gene sequence in
LGV and non-LGV Chlamydia strains leads to different pmpD
expression patterns, we examined pmpD expression profiling in C.
trachomatis serovars A, D, and L2. The pmpD gene transcriptional
pattern with up-regulation at 12–24 h p.i. described in this study
suggests that the PmpD protein may be involved in growth and
division of chlamydial RBs. These results are in agreement with
our earlier results [19] and those of Belland et al [20], Nicholson et
al [21], and Maurer et al [22]. However, when Nunes et al
examined the transcription of the pmp gene family in both
reference and clinical strains of C. trachomatis serovars E and L2,
they found that pmpD was the latest (36 h p.i) up-regulated gene,
suggesting a different role for the PmpD protein in transformation
from RBs to EBs and integrity of EB outer membrane [11]. We
have no explanation for why our results differ from those of Nunes
et al, but different infection conditions, dissimilar primer designs,
and distinctive qRT-PCR parameters may have led to those
discrepancies. Between all three serovars, pmpD expression was
highest in serovar A and lowest in serovar D which might be
explained by differential timing of the developmental phases
during the life cycle of these serovars. Notably, the pattern of pmpD
gene temporal transcription in both a clinical isolate and the
prototype strain of serovar D was nearly identical, but in serovar
L2 it was not. In addition, the pmpD relative expression in
prototype strains was significantly higher than in clinical isolates
during the period of exponential growth and replication of
Chlamydia. We believe that the differences in pmpD expression
patterns may be due to the divergence in the pmpD gene sequence
in prototype and clinical strains or mRNA amounts which may
vary from strain to strain based specific needs [11]. Because of
these variations, more extensive studies involving multiple clinical
isolates are needed in order to draw a definite conclusion about
any trends in the pmpD gene transcription pattern in clinical
isolates versus prototype strains.
When the PmpD protein post-translational processing pattern
was examined during the developmental cycle of C. trachomatis
serovars A and D, it was found to be very similar to that observed
in serovar L2 [19]. The results of MS analysis indicated that the
creation of the <120 kDa protein represents classical autotran-
sporter pathway of processing of PmpD with a cleavage site
between the PD and TD (aa 1242 and 1243) recognized by outer
membrane proteases. However, the peptide composition of the
Figure 12. Low (28uC) temperature induced persistent infection of culture cells with C. trachomatis does not block PmpD post-
translational processing. McCoy cells were infected with C. trachomatis serovar L2, fixed with methanol at 24 (A and D) h p.i. at 37uC and 48 (B and
E) and 120 (C and F) h p.i. at 28uC and reacted with mAb against chlamydial MOMP (green) in combination with pAb against fragment 2 of PmpD
(red) (A–C) or pAb against chlamydial HSP60 protein (red) (D–F) (internal control). RBs produced during persistent infection are abnormally large with
thin cell wall (B–C and E–F) compared with uniformly sized and round shaped RBs (A and D) produced during normal infection. Arrow indicates
localization of PmpD during the chlamydial life cycle on the surface of aberrant RBs (A) or in the inclusion lumen outside Chlamydia (red spots) (B).
When reacted with anti-HSP60 pAb, no material was visible outside Chlamydia. Note that the rate of PmpD secretion outside Chlamydia is much
lower and slower when compared with normal (37uC) infection. The photographs were made using a Leica SL confocal microscope.
doi:10.1371/journal.pone.0005191.g012
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additional/alternative cleavage site located in the middle of the
PD (between aa 698 and 699) is recognized in order to allow its
secretion outside bacteria [36–39]. There is a possibility that the
<65 and 80 kDa proteins resulted from cleavage of PmpD by
another AT protein with serine protease-like activity [40] since the
peptide bond between aa 698 (arginine) and 699 (glycine)
represents one of the cleavage sites recognized by serine proteases
[41]. The IMF microscopy with pAb against different PmpD
fragments demonstrated that the PD is linked to the surface of RBs
prior to its secretion into the inclusion lumen and the TD which is
a part of the <80 kDa protein, remains inside the cell wall of
Chlamydia. Interestingly, the <30 kDa protein band correlating to
the cleaved TD of PmpD was never found in our experiments
suggesting its quick degradation due to potential high toxicity of
the beta-barrel to bacteria [42,43].
The PmpD post-translational products identified in this work
(<120, 65, and 80 kDa fragments) are very similar to those
described by Swanson et al (111, 73, and 82 kDa fragments) [18].
However, Swanson et al [18] proposed the cleavage of PmpD with
the primary formation of Chlamydia-associated 73 and 82 kDa
fragments starting at mid (24 h p.i.) infection and secondary
formation of a soluble 111 kDa fragment followed by its cleavage
and subsequent production of 73 and 30 kDa proteins occurring at
late (30–48 h p.i.) infection. Contrary to their findings, we found
the PD of PmpD (the <120 kDa protein) secreted as early as 24 h
p.i. Two additional PmpD post-translational products which
resulted from non-conventional processing, the <65 kDa and
80 kDa fragments, appear at later time points after infection (30–
48 h p.i.). Notably, the soluble 30 kDa segment of PmpD first
described by Swanson et al [18], never reacted in an immunoblot
with antibodies employed in our studies which could be due to
recognition of different epitopes in Chlamydia by antibodies
generated in our study. The mode of PmpD processing suggested
in our work is supported by that of Wehrl et al [16], who also
proposed the earlier cleavage of the PD of PmpD during the life
cycle of C. pneumoniae. Notably, confocal microscopy demonstrated
staining of the protein material outside of chlamydial organisms in
the inclusion lumen with the anti-PmpD pAb starting at 24 h after
infection, thus confirming the timing of PmpD secretion in an
immunoblot.
To investigate the mode of action of penicillin in our previous
work [19], PmpD post-translational processing was examined at
low (28uC) temperature. To our knowledge, this is the first study
describing expression of a Pmp during persistent infection. We
demonstrated that the incomplete chlamydial developmental cycle
which occurs during low temperature induced persistent infection
does not prevent PmpD post-translational processing. Thus, it
appears that penicillin specifically inhibits membrane proteases
including signal peptidase I and other serine proteases which
cleave an autotransporter protein during its multistep processing
[23,44] resulting in blockage of PmpD processing [19]. Associated
with altered development during Chlamydia life cycle, persistent
infection is considered a significant aspect in the pathogenesis of
chlamydial infection [45,46]. Our findings that the PmpD
processing and secretion outside Chlamydia are not inhibited
during low temperature induced persistent infection indicate that
PmpD and its post-translational products may play an important
role in survival of Chlamydia in harsh environmental conditions
contributing to mediation between the host cell and Chlamydia.
However, the PmpD expression pattern during persistent infection
could be different depending on the factors inducing this infection.
For instance, Klos et al [47] and Goellner et al [48] demonstrated
that persistent infection induced by variety of factors resulted in
dissimilar transcription pattern of a range of genes in C. pneumoniae
and C. psittaci respectively. In addition, it was shown that another
important component of the chlamydial outer membrane, the
MOMP protein, was so greatly reduced during IFN-c induced
infection that anti-MOMP mAb did not stain chlamydial
inclusions in culture cells [49], though in our study, Chlamydia
organisms were clearly stained with anti-MOMP antibodies. More
experiments need to be carried out to explain the role of
chlamydial Pmps in the pathogenesis of persistent chlamydial
infection.
In summary, the variability in the nucleotide sequence of the
pmpD gene of C. trachomatis serovars A, D, and L2, which have
different tissue tropisms, did not lead to significant dissimilarities in
the pmpD gene transcription profiling and the PmpD protein post-
translational processing pattern, thus indicating that the pmpD
gene may have similar functions in all three Chlamydia serovars. In
addition, the peptide profile of the PmpD post-translational
products, the mechanism of their formation, and their localization
during the chlamydial life cycle are in agreement with the general
theory that PmpD is an autotransporter protein.
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Figure 13. PmpD processing and secretion at 28uC. McCoy cells
infected with C. trachomatis serovar L2 were incubated at 28uC,
harvested every 48 h, and soluble fractions prepared as described in
METHODS. The proteins in each soluble fraction were reacted in an
immunoblot with antibodies against fragment 2 of PmpD. Lane 1, 48 h
p.i. Lane 2, 96 h p.i. Lane 3, 144 h p.i. Lane 4, 192 h p.i.
doi:10.1371/journal.pone.0005191.g013
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